Hong Kong stocks surged | Sino Biopharm (01801.HK) surged over 7% in the morning Recently reached a commercial partnership agreement with Eli Lilly's Verzenio in mainland China.

According to the Wise Wealth APP, Xin Da Biological (01801.HK) rose more than 7% in the morning. As of the time of writing, it had risen by 7.16% to 85.3 Hong Kong dollars, with a turnover of 1.518 billion Hong Kong dollars.